Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Fenofibrate[1] Fenofibrate (Fenofibrate)[1] Fenofibrate (Fenofibrate, FENOFIBRATE) 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[6] 8, 79, 93, 94, 97, 265 💬
2Fenofibrate 160MG[1] Fenofibrate (Fenofibrate)[1] Fenofibrate (Fenofibrate, FENOFIBRATE) 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 97 💬
3Fenofibrate 200MG[1] Fenofibrate (Fenofibrate)[1] Fenofibrate (Fenofibrate, FENOFIBRATE) 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
4Fenofibrate combined with ursodeoxycholic acid[2] Fenofibrate (Fenofibrate),
Ursodeoxycholic acid
[2] Fenofibrate (Fenofibrate, FENOFIBRATE),
Ursodiol 💬
[2] NR1C1,
NR1H4 💬
[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬
5Fenofibrate IN combination with ursodeoxycholic acid[1] Fenofibrate (Fenofibrate)[1] Fenofibrate (Fenofibrate, FENOFIBRATE) 💬 [1] NR1C1 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 93 💬